$8.26 Billion is the total value of Redmile Group, LLC's 87 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 32.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $1,148,422,000 | +127.5% | 12,629,737 | 0.0% | 13.91% | +50.0% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $476,127,000 | +46.1% | 20,620,490 | -10.6% | 5.76% | -3.6% |
| ALLK | Buy | ALLAKOS INC | $373,443,000 | +89.0% | 2,667,451 | +10.0% | 4.52% | +24.7% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $308,457,000 | +276.5% | 3,778,262 | +13.6% | 3.74% | +148.3% |
| IGMS | IGM BIOSCIENCES INC | $302,433,000 | +19.6% | 3,425,455 | 0.0% | 3.66% | -21.1% | |
| STTK | New | SHATTUCK LABS INC | $294,540,000 | – | 5,619,914 | +100.0% | 3.57% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $270,065,000 | +4.1% | 918,307 | -7.1% | 3.27% | -31.4% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $253,275,000 | +3.4% | 4,437,968 | -7.1% | 3.07% | -31.8% |
| NVTA | Buy | INVITAE CORP | $220,059,000 | +2503.3% | 5,263,309 | +2599.1% | 2.66% | +1619.4% |
| ADCT | Buy | ADC THERAPEUTICS SA | $216,349,000 | +3.2% | 6,758,794 | +6.4% | 2.62% | -31.9% |
| OSH | Buy | OAK STR HEALTH INC | $178,936,000 | +26.2% | 2,925,711 | +10.3% | 2.17% | -16.7% |
| MDVL | New | MEDAVAIL HOLDINGS INC | $176,457,000 | – | 11,724,726 | +100.0% | 2.14% | – |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $168,670,000 | +91.0% | 2,720,489 | -0.4% | 2.04% | +26.0% |
| STOK | Buy | STOKE THERAPEUTICS INC | $166,358,000 | +94.8% | 2,686,234 | +5.4% | 2.01% | +28.4% |
| REPL | Buy | REPLIMUNE GROUP INC | $152,348,000 | +98.7% | 3,993,399 | +19.9% | 1.84% | +31.0% |
| ABBV | New | ABBVIE INC | $148,821,000 | – | 1,388,904 | +100.0% | 1.80% | – |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $144,446,000 | +52.3% | 3,309,194 | -1.1% | 1.75% | +0.5% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $140,571,000 | +173.9% | 2,896,589 | -0.1% | 1.70% | +80.7% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $134,722,000 | +49.8% | 6,863,070 | -1.1% | 1.63% | -1.2% |
| GILD | Sell | GILEAD SCIENCES INC | $133,348,000 | -26.5% | 2,288,846 | -20.2% | 1.62% | -51.5% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $125,508,000 | +57.8% | 2,416,406 | -0.7% | 1.52% | +4.1% |
| EPZM | Buy | EPIZYME INC | $102,630,000 | +3.5% | 9,450,305 | +13.7% | 1.24% | -31.7% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $100,502,000 | +55.4% | 1,675,036 | +11.5% | 1.22% | +2.5% |
| SNY | Buy | SANOFIsponsored adr | $96,436,000 | +10.3% | 1,984,690 | +13.9% | 1.17% | -27.2% |
| RGNX | Sell | REGENXBIO INC | $96,322,000 | +57.1% | 2,123,492 | -4.7% | 1.17% | +3.6% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $94,138,000 | – | 815,681 | +100.0% | 1.14% | – |
| NRIX | Buy | NURIX THERAPEUTICS INC | $93,581,000 | +3.4% | 2,846,125 | +9.7% | 1.13% | -31.8% |
| AVIR | New | ATEA PHARMACEUTICALS INC | $93,241,000 | – | 2,231,710 | +100.0% | 1.13% | – |
| RPTX | Buy | REPARE THERAPEUTICS INC | $90,816,000 | +22.7% | 2,647,696 | +10.1% | 1.10% | -19.1% |
| ALVR | Sell | ALLOVIR INC | $89,396,000 | +39.3% | 2,325,595 | -0.3% | 1.08% | -8.1% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $87,621,000 | +54.4% | 2,832,888 | +1.4% | 1.06% | +1.8% |
| ANNX | Buy | ANNEXON INC | $86,304,000 | -17.1% | 3,448,030 | +0.2% | 1.04% | -45.3% |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $82,786,000 | +438.4% | 960,400 | +135.7% | 1.00% | +255.3% |
| CI | Sell | CIGNA CORP NEW | $79,752,000 | +18.7% | 383,093 | -3.4% | 0.97% | -21.7% |
| UNH | New | UNITEDHEALTH GROUP INC | $78,776,000 | – | 224,639 | +100.0% | 0.95% | – |
| ANTM | New | ANTHEM INC | $78,453,000 | – | 244,332 | +100.0% | 0.95% | – |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $76,984,000 | +0.2% | 3,388,376 | -0.1% | 0.93% | -33.9% |
| NVRO | Sell | NEVRO CORP | $76,841,000 | +20.0% | 443,909 | -3.4% | 0.93% | -20.9% |
| IMGN | Buy | IMMUNOGEN INC | $67,907,000 | +80.0% | 10,528,179 | +0.5% | 0.82% | +18.8% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $66,246,000 | -1.0% | 4,537,400 | -3.7% | 0.80% | -34.7% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $59,922,000 | -16.7% | 2,322,557 | -0.6% | 0.73% | -45.0% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $59,513,000 | +152.6% | 452,295 | -3.0% | 0.72% | +66.9% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $58,259,000 | +16.4% | 4,131,869 | -1.0% | 0.70% | -23.3% |
| BIIB | Sell | BIOGEN INC | $52,950,000 | -43.0% | 216,247 | -34.0% | 0.64% | -62.4% |
| ICUI | Buy | ICU MED INC | $51,789,000 | +79.3% | 241,454 | +52.8% | 0.63% | +18.3% |
| ZYME | Sell | ZYMEWORKS INC | $51,433,000 | +0.2% | 1,088,300 | -1.2% | 0.62% | -33.9% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $47,508,000 | +61.0% | 2,711,616 | +36.3% | 0.58% | +6.1% |
| BNTX | Sell | BIONTECH SEsponsored ads | $47,342,000 | -44.7% | 580,746 | -53.0% | 0.57% | -63.5% |
| UBER | New | UBER TECHNOLOGIES INC | $42,526,000 | – | 833,845 | +100.0% | 0.52% | – |
| BCEL | Sell | ATRECA INC | $39,988,000 | +12.3% | 2,476,068 | -2.8% | 0.48% | -26.0% |
| AMED | Sell | AMEDISYS INC | $39,154,000 | +18.1% | 133,480 | -4.8% | 0.47% | -22.0% |
| SLQT | Buy | SELECTQUOTE INC | $38,278,000 | +39.5% | 1,844,719 | +36.1% | 0.46% | -8.1% |
| QURE | Sell | UNIQURE NV | $37,174,000 | -10.6% | 1,028,898 | -8.9% | 0.45% | -41.0% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $33,334,000 | +18.2% | 265,736 | -4.4% | 0.40% | -22.0% |
| CNC | New | CENTENE CORP DEL | $33,314,000 | – | 554,962 | +100.0% | 0.40% | – |
| CTLT | Sell | CATALENT INC | $32,732,000 | +16.0% | 314,519 | -4.5% | 0.40% | -23.6% |
| RCEL | Sell | AVITA THERAPEUTICS INC | $31,723,000 | -29.1% | 1,707,386 | -4.1% | 0.38% | -53.3% |
| PPD | Sell | PPD INC | $28,170,000 | -10.7% | 823,192 | -3.5% | 0.34% | -41.1% |
| ARDX | ARDELYX INC | $22,736,000 | +23.2% | 3,514,100 | 0.0% | 0.28% | -18.9% | |
| IMTX | Sell | IMMATICS N.V | $22,317,000 | -1.2% | 2,068,301 | -2.9% | 0.27% | -34.9% |
| PAND | Buy | PANDION THERAPEUTICS INC | $20,771,000 | +61.9% | 1,398,705 | +24.9% | 0.25% | +6.8% |
| HOOK | HOOKIPA PHARMA INC | $20,438,000 | +17.1% | 1,842,902 | 0.0% | 0.25% | -22.8% | |
| ABCL | New | ABCELLERA BIOLOGICS INC | $20,120,000 | – | 500,000 | +100.0% | 0.24% | – |
| LUNG | New | PULMONX CORP | $18,981,000 | – | 275,000 | +100.0% | 0.23% | – |
| CABA | Sell | CABALETTA BIO INC | $17,201,000 | +14.4% | 1,378,319 | -0.6% | 0.21% | -24.6% |
| PROF | Buy | PROFOUND MED CORP | $16,966,000 | +16.6% | 825,197 | +0.0% | 0.20% | -23.2% |
| CTSO | Sell | CYTOSORBENTS CORP | $16,371,000 | -2.3% | 2,054,131 | -2.2% | 0.20% | -35.7% |
| STXS | STEREOTAXIS INC | $15,796,000 | +42.2% | 3,103,327 | 0.0% | 0.19% | -6.4% | |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $14,130,000 | +11.1% | 711,500 | +13.8% | 0.17% | -26.6% |
| GRTS | GRITSTONE ONCOLOGY INC | $12,056,000 | +48.7% | 3,059,794 | 0.0% | 0.15% | -2.0% | |
| XERS | XERIS PHARMACEUTICALS INC | $11,795,000 | -17.0% | 2,397,441 | 0.0% | 0.14% | -45.2% | |
| VSPR | New | VESPER HEALTHCARE ACQSTN COR | $11,310,000 | – | 1,000,000 | +100.0% | 0.14% | – |
| YMTX | New | YUMANITY THERAPEUTICS INC | $10,387,000 | – | 611,003 | +100.0% | 0.13% | – |
| AYLA | Buy | AYALA PHARMACEUTICALS INC | $7,606,000 | -3.1% | 667,816 | +0.2% | 0.09% | -36.1% |
| SEER | New | SEER INC | $7,018,000 | – | 125,000 | +100.0% | 0.08% | – |
| APRE | Sell | APREA THERAPEUTICS INC | $6,242,000 | -88.6% | 1,268,718 | -44.1% | 0.08% | -92.4% |
| EAR | New | EARGO INC | $5,804,000 | – | 129,488 | +100.0% | 0.07% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $5,415,000 | -50.8% | 1,216,844 | -52.3% | 0.07% | -67.3% |
| MASS | New | 908 DEVICES INC | $4,271,000 | – | 75,000 | +100.0% | 0.05% | – |
| OM | OUTSET MED INC | $3,979,000 | +13.7% | 70,000 | 0.0% | 0.05% | -25.0% | |
| TCDA | Sell | TRICIDA INC | $3,182,000 | -87.7% | 451,377 | -84.2% | 0.04% | -91.8% |
| RIGL | RIGEL PHARMACEUTICALS INC | $2,606,000 | +45.8% | 744,582 | 0.0% | 0.03% | -3.0% | |
| SYRS | SYROS PHARMACEUTICALS INC | $2,303,000 | +22.7% | 212,291 | 0.0% | 0.03% | -17.6% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $622,000 | -55.2% | 79,018 | -51.7% | 0.01% | -69.2% |
| VAPO | VAPOTHERM INC | $672,000 | -7.3% | 25,000 | 0.0% | 0.01% | -38.5% | |
| OVID | OVID THERAPEUTICS INC | $282,000 | -59.7% | 121,950 | 0.0% | 0.00% | -76.9% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $13,000 | +8.3% | 10,229 | 0.0% | 0.00% | – | |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -25,162 | -100.0% | -0.01% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -120,940 | -100.0% | -0.08% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -200,000 | -100.0% | -0.20% | – |
| FSDC | Exit | FS DEV CORP | $0 | – | -1,000,000 | -100.0% | -0.21% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -1,719,247 | -100.0% | -0.23% | – |
| LMNX | Exit | LUMINEX CORP DEL | $0 | – | -914,107 | -100.0% | -0.44% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -83,412 | -100.0% | -0.63% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -741,129 | -100.0% | -0.69% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -1,422,049 | -100.0% | -1.00% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -3,234,934 | -100.0% | -5.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.